Sign in

    Randall A. Lipps

    President, Chief Executive Officer, and Chairman of the Board of Directors at Omnicell Inc
    Board
    Since October 2002
    Age
    67 years
    Education
    Holds both a B.S. in Economics and a B.B.A. from Southern Methodist University.
    Tenure
    Joined Omnicell by founding the company in September 1992 and was promoted to President, Chief Executive Officer, and Chairman of the Board of Directors in October 2002.

    Also at Omnicell Inc

    NEE
    Nchacha E. Etta
    Executive Vice President and Chief Financial Officer
    NN
    Nnamdi Njoku
    Executive Vice President and Chief Operating Officer

    About

    Randall A. Lipps is an accomplished executive known for his long-standing leadership in the healthcare industry. Born in 1957, he has developed a strong foundation through his academic achievements, holding both a B.S. in Economics and a B.B.A. from Southern Methodist University.

    His professional journey began with the founding of Omnicell in September 1992, where he initially assumed the roles of Chairman of the Board and Director. His visionary leadership and strategic direction led to his promotion in October 2002 to President, Chief Executive Officer, and Chairman of the Board of Directors.

    Beyond his work at Omnicell, his contributions extend into various leadership roles and philanthropic efforts, including board memberships and involvement with organizations that support the healthcare community, such as the American Nurses Foundation. This blend of entrepreneurial spirit, academic excellence, and commitment to innovation has cemented his reputation as a key figure in transforming pharmacy care delivery and advancing healthcare practices.

    $OMCL Performance Under Randall A. Lipps

    Past Roles

    OrganizationRoleDate RangeDetails
    Omnicell, Inc. DirectorSep 1992 - Oct 2002 Held as a Director prior to being named President, CEO, and retaining Chairman responsibilities

    External Roles

    OrganizationRoleDate RangeDetails
    American Nurses Foundation Member of the Board of Trustees N/A [N/A]Current active position outside OMCL

    Fixed Compensation

    Data from  FY 2023
    Component NameAmountPayment ScheduleAdditional Details
    Base Salary$813,100 AnnualAnnualized salary for 2023
    Stock Awards$9,174,870 Granted in 2023Grant date fair value of stock awards tied to performance metrics
    All Other Compensation$49,000 As incurred/AnnualIncludes 401(k) matching ($15,000 ), executive physical exam reimbursement ($10,000 ), and personal use of company aircraft ($24,000 )

    Performance Compensation

    Data from  FY 2023

    Cash Bonus Incentive

    MetricValueDetails
    Incentive Target$1,016,375 Total bonus target for 2023
    Total Cash Bonus Earned$985,102 Achieved 77% of the bonus target
    Corporate Scorecard Weight50% 50% of potential bonus determined by company-wide financial objectives
    Required Corporate Rating90% Minimum rating required on the Corporate Scorecard for any payout
    Corporate MetricsTotal Revenues: $1.150B, Advanced Services Revenues: $203.4M, Operational Expenditures: $459.5M Financial objectives evaluated quarterly
    Individual Targets10%-25% Set quarterly with 25% of bonus conditional on direct reports' performance
    Evaluation PeriodQuarterly Performance measured each quarter in 2023
    Payment ConditionContingent on meeting thresholds Bonus paid only if Corporate Threshold Targets are met

    Equity Awards Performance Component

    ComponentDetailValue/Description
    RSUsGrant DateJune 1, 2023
    Grant Date Fair Value$72.92 per share
    Vesting Schedule37.5% vest on August 15, 2024; remaining 62.5% vest in 10 equal quarterly installments over 3 years
    PSUsPerformance MetricsVesting based on TSR: Threshold at 35th percentile (50% payout), Target at 50th percentile (100% payout), Maximum at 90th percentile (200% payout)
    2023 OutcomeCompany TSR at 34th percentile; no PSUs vested
    AdjustmentPSU grant reduced by 9,000 shares, final target of 38,000 PSU shares